Home > Health & Wellness > Health Library > Multiple Sclerosis: Clinical Trials
During clinical trials, people who have
multiple sclerosis (MS) participate in studies that
test new therapies for the disease. The therapies tested in clinical trials
have shown promise in laboratory and animal research, but they may not have
been shown to be safe and effective for humans yet. Each trial requires that a
person meet specific requirements (involving, for example, age, time since
diagnosis, and course of MS) in order to ensure that the results will be clear
enough to be useful.
Medicines being tested in clinical trials pass through four
Call the National
Multiple Sclerosis Society (1-800-FIGHT-MS, or 1-800-344-4867) or the Brain
Resources and Information Network of the National Institute of Neurological
Disorders and Stroke (1-800-352-9424) for information on clinical trials. Or
visit the National Institutes of Health clinical trials website at
www.ClinicalTrials.gov. Discuss with your doctor, nurse, or therapist the
possibility of participating in a trial. Current clinical trials involve
testing new medicines, higher doses of existing medicines, and combination
February 15, 2012
Adam Husney, MD - Family Medicine & Anne C. Poinier, MD - Internal Medicine & Barrie J. Hurwitz, MD - Neurology
How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Call First Nurse 24 Hours a Day for free health care advice, resources and referrals!
Ames: 515-239-6877In Iowa: 800-524-6877
Search health information online in our Mulimedia Health Library.
Use our interactive symptom checker to evaluate your symptoms and determine appropriate action or treatment.
Patient Privacy |
Net Learning for Employees |
MGMC PACS for Physicians
1111 Duff Avenue Ames, IA 50010 - 515-239-2011 - email@example.com
©2014 Mary Greeley Medical Center - All rights reserved.